AI Article Synopsis

  • Investigated lipid nano-emulsions (LNEs) with a mean droplet size of about 50 nm as drug carriers for paclitaxel (TXL) to create an alternative to the existing formulation Taxol.
  • TXL was successfully incorporated into LNEs at 2.0 mg/ml, maintaining particle size and preventing drug precipitation, while showing similar cytotoxic effects on HeLa cells as TXL alone.
  • Despite the effective delivery of TXL, LNEs had lower cellular accumulation compared to the standard method, indicating their potential as a drug vehicle but highlighting the need for improved accumulation in target cells.

Article Abstract

Lipid nano-emulsions (LNEs) having a mean droplet size of approximately 50 nm were investigated as drug carriers for paclitaxel (TXL) to achieve its satisfactory loadings and to develop a pharmaceutically acceptable alternative to the current formulation, Taxol. TXL was incorporated into the LNEs at 2.0 mg/ml without changes in particle size or drug precipitation. In the cytotoxicity study, TXL-loaded LNEs had cytotoxicity to HeLa cells equivalent to that of TXL alone; the 50% growth inhibitory concentrations (IC(50)) of TXL-loaded LNEs and TXL alone were 1.53 +/- 0.23 nM and 1.76 +/- 0.08 nM, respectively. However, a cellular accumulation study using 1,6-diphenyl-1,3,5-hexatriene (DPH) as a fluorescent probe showed that the accumulation of DPH-loaded LNEs in HeLa cells was remarkably lower than that of DPH alone. These results indicated that LNEs were a useful vehicle for TXL, even though LNEs themselves could not be efficiently accumulated in HeLa cells.

Download full-text PDF

Source
http://dx.doi.org/10.3109/02652040903515482DOI Listing

Publication Analysis

Top Keywords

hela cells
12
cellular accumulation
8
lipid nano-emulsions
8
txl-loaded lnes
8
lnes
7
txl
5
characterization vitro
4
vitro cytotoxicity
4
cytotoxicity cellular
4
accumulation paclitaxel-loaded
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!